Millennium Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Buy |
+195,357
| New | +$3.64M | ﹤0.01% | 2286 |
|
|
2025
Q1 | – | Sell |
-90,436
| Closed | -$1.97M | – | 4061 |
|
|
2024
Q4 | $1.97M | Buy |
90,436
+55,682
| +160% | +$1.21M | ﹤0.01% | 2523 |
|
|
2024
Q3 | $952K | Buy |
+34,754
| New | +$952K | ﹤0.01% | 2949 |
|
|
2024
Q2 | – | Sell |
-277,213
| Closed | -$8.32M | – | 4070 |
|
|
2024
Q1 | $8.32M | Buy |
277,213
+243,249
| +716% | +$7.3M | ﹤0.01% | 1625 |
|
|
2023
Q4 | $353K | Buy |
+33,964
| New | +$353K | ﹤0.01% | 3337 |
|
|
2023
Q1 | – | Sell |
-144,597
| Closed | -$914K | – | 4624 |
|
|
2022
Q4 | $914K | Buy |
144,597
+13,638
| +10% | +$86.2K | ﹤0.01% | 3240 |
|
|
2022
Q3 | $2.95M | Buy |
130,959
+13,747
| +12% | +$310K | ﹤0.01% | 2603 |
|
|
2022
Q2 | $2.25M | Buy |
117,212
+29,474
| +34% | +$566K | ﹤0.01% | 2792 |
|
|
2022
Q1 | $4.07M | Buy |
87,738
+45,013
| +105% | +$2.09M | ﹤0.01% | 2469 |
|
|
2021
Q4 | $3.03M | Buy |
+42,725
| New | +$3.03M | ﹤0.01% | 2631 |
|
|
2021
Q3 | – | Sell |
-4,007
| Closed | -$627K | – | 5177 |
|
|
2021
Q2 | $627K | Buy |
4,007
+1,298
| +48% | +$203K | ﹤0.01% | 4036 |
|
|
2021
Q1 | $513K | Sell |
2,709
-1,363
| -33% | -$258K | ﹤0.01% | 3650 |
|
|
2020
Q4 | $511K | Buy |
4,072
+1,739
| +75% | +$218K | ﹤0.01% | 3225 |
|
|
2020
Q3 | $254 | Sell |
2,333
-15,180
| -87% | -$1.65K | ﹤0.01% | 3152 |
|
|
2020
Q2 | $2.1M | Buy |
17,513
+2,810
| +19% | +$338K | ﹤0.01% | 1990 |
|
|
2020
Q1 | $1.48M | Buy |
14,703
+6,893
| +88% | +$692K | ﹤0.01% | 1796 |
|
|
2019
Q4 | $1.89M | Buy |
+7,810
| New | +$1.89M | ﹤0.01% | 2153 |
|
|
2018
Q3 | – | Sell |
-6,984
| Closed | -$1.51M | – | 3548 |
|
|
2018
Q2 | $1.51M | Buy |
+6,984
| New | +$1.51M | ﹤0.01% | 2293 |
|